2-Arachidonoylglycerol is an endocannabinoid, an endogenous agonist of the CB₁ receptor and the primary endogenous ligand for the CB2 receptor. It is an ester formed from the omega-6 fatty acid arachidonic acid and glycerol. From Wikipedia
Researchers find the drug reduces pain by inhibiting 2-AG synthesis, challenging longstanding assumptions and paving the way for safer alternatives.